CervoMed Inc. (NASDAQ:CRVO) Financings

CervoMed Inc.

Financings

RaiseDate
Registered direct offering of common stock
Closed: US$10M raised · US$4 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Jun 22, 2026
Registered direct offering of common stock
Announced: US$10M · US$4 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Jun 18, 2026
Private placement of units (common stock or pre-funded warrant, Series B warrant and Series C warrant)
Announced: about US$10.5M · US$3.14 a unit · Warrants at US$3.32
Buyers: Joshua S. Boger; Trusts related to John J. Alam and Sylvie Grégoire
Insiders: Supported by insiders including board chair Joshua S. Boger and trusts related to CEO John J. Alam and director Sylvie Grégoire
Use of proceeds: Research and development of neflamapimod, working capital and general corporate purposes
Jun 10, 2026

Read by 6ix AI from the company's releases